An Assessment of the CDKN2A Variant Ala148Thr as a Nevus/Melanoma Susceptibility Allele
- 1 October 2002
- journal article
- Published by Elsevier in Journal of Investigative Dermatology
- Vol. 119 (4), 961-965
- https://doi.org/10.1046/j.1523-1747.2002.01825.x
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Teaching non-specialist health care professionals how to identify the atypical mole syndrome phenotype: a multinational studyBritish Journal of Dermatology, 2000
- Expression of the Tumor Suppressor Gene Product p16INK4 in Benign and Malignant Melanocytic LesionsJournal of Investigative Dermatology, 1998
- Prevalence of p16 and CDK4 germline mutations in 48 melanoma-prone families in France. The French Familial Melanoma Study Group [published erratum appears in Hum Mol Genet 1998 May;7(5):941]Human Molecular Genetics, 1998
- Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindredsHuman Molecular Genetics, 1995
- Mutations associated with familial melanoma impair p16INK4 functionNature Genetics, 1995
- Family studies in melanoma: identification of the atypical mole syndrome (AMS) phenotypeMelanoma Research, 1994
- A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4Nature, 1993
- How common is the atypical mole syndrome phenotype in apparently sporadic melanoma?Journal of the American Academy of Dermatology, 1993
- The Dutch FAMMM family material: Clinical and genetic dataCytogenetic and Genome Research, 1992